Recordati Ireland was established in 2002 and is based in Ringaskiddy, Co. Cork, Ireland. It is part of the Recordati group, an international pharmaceutical company listed on the Italian Stock Exchange with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of value-adding medicines that improve quality of life and help people to enjoy longer, healthier and more productive lives. Headquartered in Milan, Italy, Recordati has operations in the main European countries, Russia and other Central and Eastern European countries, Turkey, North Africa, Japan, the United States of America, Mexico and some South American countries. We cover a wide range of pharmaceuticals in a number of therapeutic areas such as, for instance, cardiology and urology as well as the treatment of rare diseases. Specifically, Recordati Ireland’s mission focus on 4 pillars - Production of the active pharmaceutical ingredient of our anti-hypertensive product “Zanidip” - Management of intercompany activities - Commercialisation and promotion on the Irish domestic market - Management of out-licensing and distribution activities through strategic partnerships in more than 100 countries.